Right now GLP-1 medicines for obesity carry high list prices that engender great debates about how many billions (hyperbolists will say trillions) of dollars treating obesity will cost healthcare systems. For the uninitiated, it’s quite natural to think of metabolic procedures and obesity medicine in terms of either/or questions. No matter that this is a […]

